Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
9.10
-0.05 (-0.55%)
Jul 29, 2026, 10:43 AM EDT - Market open
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $54.44 million as of July 29, 2026. Its market cap has increased by 54.16% in one year.
Market Cap
54.44M
Enterprise Value
-88.95M
1-Year Change
54.16%
Ranking
Category
Stock Price
$9.10
ChartMarket Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $54.44M, a decrease of -87.24%. That is a compound annual growth rate of -35.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 54.44M | 61.98% |
| Dec 31, 2025 | 33.61M | -19.94% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 58.78M |
| Cardiff Oncology | 57.91M |
| Boundless Bio | 55.71M |
| MiNK Therapeutics | 53.32M |
| TScan Therapeutics | 51.30M |
| Veraxa Biotech AG | 51.19M |
| Immutep | 49.47M |
| Dogwood Therapeutics | 49.44M |